Human Genome Epidemiology Literature Finder
|
Records 1 - 6 (of 6 Records) |
| Query Trace: Tuberculosis and CES2[original query] |
|---|
| Genetic variation in carboxylesterase genes and susceptibility to isoniazid-induced hepatotoxicity. The pharmacogenomics journal 2010 Dec 10 (6): 524-36. Yamada S, Richardson K, Tang M, Halaschek-Wiener J, Cook V J, Fitzgerald J M, Elwood K, Marra F, Brooks-Wilson |
| Relationship between CES2 genetic variations and rifampicin metabolism. The Journal of antimicrobial chemotherapy 2013 Jun 68 (6): 1281-4. Song Sang Hoon, Chang Ho Eun, Jun Sun Hee, Park Kyoung Un, Lee Jae Ho, Lee Eun-Mi, Song Young-Han, Song Jungh |
| Effect of Genetic Variation of NAT2 on Isoniazid and SLCO1B1 and CES2 on Rifampin Pharmacokinetics in Ghanaian Children with Tuberculosis. Antimicrobial agents and chemotherapy 2017 Dec . Dompreh Albert, Tang Xiaoli, Zhou Jianlin, Yang Hongmei, Topletz Ariel, Adu Ahwireng Eugene, Antwi Sampson, Enimil Antony, Langaee Taimour, Peloquin Charles A, Court Michael H, Kwara Awewu |
| Influence of Single Nucleotide Polymorphisms on Rifampin Pharmacokinetics in Tuberculosis Patients. Antibiotics (Basel, Switzerland) 2020 6 9 (6): . Thomas Levin, Sekhar Miraj Sonal, Surulivelrajan Mallayasamy, Varma Muralidhar, Sanju Chidananda S V, Rao Mahad |
| Decreased plasma rifapentine concentrations associated with AADAC single nucleotide polymorphism in adults with tuberculosis. The Journal of antimicrobial chemotherapy 2020 Dec . Weiner Marc, Gelfond Jon, Johnson-Pais Teresa L, Engle Melissa, Johnson John L, Whitworth William C, Bliven-Sizemore Erin, Nsubuga Pheona, Dorman Susan E, Savic Rada, |
| Effect of Genetic Variations in Drug-Metabolizing Enzymes and Drug Transporters on the Pharmacokinetics of Rifamycins: A Systematic Review. Pharmacogenomics and personalized medicine 2022 15 561-571. Sileshi Tesemma, Mekonen Gosaye, Makonnen Eyasu, Aklillu Ele |
- Page last reviewed:Feb 1, 2024
- Content source: